BPC-157 + KPV Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: gut barrier and inflammatory signaling

Structural Blend blend Blend verified

Also known as: BPC/KPV

Quick Facts

Reference Sizes
10 mg total (5 mg + 5 mg), vendor-reported, Oral capsules 500 ug + 500 ug, vendor-specific
Components
BPC-157 + KPV
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
No published compatibility or mixed-solvent study; handle component evidence separately

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
BPC-157
Calculator Profile
Component
KPV
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Catalog Description

This is a market-defined combination rather than a studied drug product. BPC-157 has mostly preclinical evidence and very limited human exposure; KPV has cell and animal anti-inflammatory research. No controlled trial establishes synergy, dosing, compatibility, sterility, or stability for a co-formulated BPC-157 plus KPV vial or oral capsule.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
No fixed-blend pharmacokinetic study
Onset
Not established
Administration Routes (Research)
Oral or SC in marketed products; neither route is validated for the combination

Reported Research Effects

Reported Research Side Effects

Data source: Component studies, FDA regulatory review, and current vendor/community market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

Current marketing commonly uses a 5 mg + 5 mg vial or 500 ug + 500 ug oral product. Community protocols are not supported by a fixed-blend trial. Keep only as a clearly labeled market/community record.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA 2026 compounding advisory meeting materials for BPC-157 and KPV — U.S. Food and Drug Administration
https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
Oral targeted KPV delivery in a mouse colitis model — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/28143741/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention BPC-157 + KPV or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top